{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T18:19:12Z","timestamp":1775326752497,"version":"3.50.1"},"reference-count":27,"publisher":"Japanese Society of Toxicology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2024]]},"DOI":"10.2131\/jts.49.95","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T22:24:44Z","timestamp":1709245484000},"page":"95-103","source":"Crossref","is-referenced-by-count":3,"title":["Possible nonimmunological toxicological mechanisms of vesnarinone-associated agranulocytosis in HL-60 cells: role of reduced glutathione as cytotoxic defense"],"prefix":"10.2131","volume":"49","author":[{"given":"Toshihisa","family":"Koga","sequence":"first","affiliation":[{"name":"Department of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Sahara","sequence":"additional","affiliation":[{"name":"Department of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadaaki","family":"Ohtani","sequence":"additional","affiliation":[{"name":"Department of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaneko","family":"Yosuke","sequence":"additional","affiliation":[{"name":"Department of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Umehara","sequence":"additional","affiliation":[{"name":"Department of Drug Metabolism and Pharmacokinetics, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aizawa, S., Nakano, M., Yaguchi, M., Kuriyama, Y., Iwase, O., Toyama, K., Tanaka, K., Hoshi, H., Sugimoto, K., Kaido, A., Imai, T., Nabeshima, R. and Handa, H. (1997): Possible involvement of bone marrow stromal cells in agranulocytosis caused by vesnarinone treatment. Acta Haematol., <b>98<\/b>, 140-146.","DOI":"10.1159\/000203608"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Alvir, J.M., Lieberman, J.A., Safferman, A.Z., Schwimmer, J.L. and Schaaf, J.A. (1993): Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N. Engl. J. Med., <b>329<\/b>, 162-167.","DOI":"10.1056\/NEJM199307153290303"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Aratani, Y. (2018): Myeloperoxidase: its role for host defense, inflammation, and neutrophil function. Arch. Biochem. Biophys., <b>640<\/b>, 47-52.","DOI":"10.1016\/j.abb.2018.01.004"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bertolet, B.D., White, B.G. and Pepine, C.J. (1994): Neutropenia occurring during treatment with vesnarinone (OPC-8212). Am. J. Cardiol., <b>74<\/b>, 968-970.","DOI":"10.1016\/0002-9149(94)90602-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Bertolet, B.D. (2004): Precautions for use and adverse effects of vesnarinone: potential mechanisms and future therapies. Drug Saf., <b>27<\/b> (Suppl 1), 11-18.","DOI":"10.2165\/00002018-200427001-00003"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Cohn, J.N., Goldstein, S.O., Greenberg, B.H., Lorell, B.H., Bourge, R.C., Jaski, B.E., Gottlieb, S.O., McGrew, F. 3rd, DeMets, D.L. and White, B.G.; Vesnarinone Trial Investigators. (1998): A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. N. Engl. J. Med., <b>339<\/b>, 1810-1816.","DOI":"10.1056\/NEJM199812173392503"},{"key":"7","unstructured":"Data on file. Tokyo, Japan; Otsuka Pharmaceutical Co., Ltd., 1996."},{"key":"8","doi-asserted-by":"crossref","unstructured":"Feldman, A.M., Bristow, M.R., Parmley, W.W., Carson, P.E., Pepine, C.J., Gilbert, E.M., Strobeck, J.E., Hendrix, G.H., Powers, E.R., Bain, R.P. and White, B.G.; Vesnarinone Study Group. (1993): Effects of vesnarinone on morbidity and mortality in patients with heart failure. N. Engl. J. Med., <b>329<\/b>, 149-155.","DOI":"10.1056\/NEJM199307153290301"},{"key":"9","doi-asserted-by":"publisher","unstructured":"Guest, I., Sokoluk, B., MacCrimmon, J. and Uetrecht, J. (1998): Examination of possible toxic and immune mechanisms of clozapine-induced agranulocytosis. Toxicology, <b>131<\/b>, 53-65.","DOI":"10.1016\/S0300-483X(98)00110-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Hawkins, C.L., Pattison, D.I. and Davies, M.J. (2002): Reaction of protein chloramines with DNA and nucleosides: evidence for the formation of radicals, protein-DNA cross-links and DNA fragmentation. Biochem. J., <b>365<\/b>, 605-615.","DOI":"10.1042\/bj20020363"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Hazell, L.J., Davies, M.J. and Stocker, R. (1999): Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins. Biochem. J., <b>339<\/b>, 489-495.","DOI":"10.1042\/bj3390489"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Johnston, A. and Uetrecht, J. (2015): Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis. Expert Opin. Drug Metab. Toxicol., <b>11<\/b>, 243-257.","DOI":"10.1517\/17425255.2015.985649"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Kaufman, D.W., Kelly, J.P., Jurgelon, J.M., Anderson, T., Issaragrisil, S., Wiholm, B.E., Young, N.S., Leaverton, P., Levy, M. and Shapiro, S. (1996): Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur. J. Haematol. Suppl., <b>60<\/b>, 23-30.","DOI":"10.1111\/j.1600-0609.1996.tb01641.x"},{"key":"14","unstructured":"Kuzell, W.C., Koets, P., Schaffarzick, R.W. and Naugler, W.E. (1955): Variation of blood glutathione during neutropenia; case report. Stanford Med. Bull., <b>13<\/b>, 284-289."},{"key":"15","doi-asserted-by":"publisher","unstructured":"Maseneni, S., Donzelli, M., Taegtmeyer, A.B., Brecht, K. and Kr\u00e4henb\u00fchl, S. (2012): Toxicity of clopidogrel and ticlopidine on human myeloid progenitor cells: importance of metabolites. Toxicology, <b>299<\/b>, 139-145.","DOI":"10.1016\/j.tox.2012.05.017"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Mastronikolis, S., Kagkelaris, K., Pagkalou, M., Tsiambas, E., Plotas, P. and Georgakopoulos, C.D. (2022): Antioxidant Defense and Pseudoexfoliation Syndrome: An Updated Review. Med. Sci. (Basel), <b>10<\/b>, 68.","DOI":"10.3390\/medsci10040068"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Pereira, A. and Dean, B. (2006): Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: a potential <i>in vitro<\/i> system for the study of agranulocytosis. Biochem. Pharmacol., <b>72<\/b>, 783-793.","DOI":"10.1016\/j.bcp.2006.06.006"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Pisciotta, A.V. (1990): Drug-induced agranulocytosis. Peripheral destruction of polymorphonuclear leukocytes and their marrow precursors. Blood Rev., <b>4<\/b>, 226-237.","DOI":"10.1016\/0268-960X(90)90002-A"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Rudin, D., Lanzilotto, A., Bachmann, F., Housecroft, C.E., Constable, E.C., Drewe, J., Haschke, M. and Kr\u00e4henb\u00fchl, S. (2019): Non-immunological toxicological mechanisms of metamizole-associated neutropenia in HL60 cells. Biochem. Pharmacol., <b>163<\/b>, 345-356.","DOI":"10.1016\/j.bcp.2019.01.011"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Thomas, E.L., Grisham, M.B. and Jefferson, M.M. (1983): Myeloperoxidase-dependent effect of amines on functions of isolated neutrophils. J. Clin. Invest., <b>72<\/b>, 441-454.","DOI":"10.1172\/JCI110992"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Thomas, E.L., Grisham, M.B., Melton, D.F. and Jefferson, M.M. (1985): Evidence for a role of taurine in the <i>in vitro<\/i> oxidative toxicity of neutrophils toward erythrocytes. J. Biol. Chem., <b>260<\/b>, 3321-3329.","DOI":"10.1016\/S0021-9258(19)83623-2"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Torii-Goto, A., Yoshimi, A., Tashiro, Y., Ukigai, M., Matsumoto, A., Ozaki, N. and Noda, Y. (2022): A reactive metabolite of clozapine induces hematopoietic toxicity in HL-60 cells undergoing granulocytic differentiation through its effect on glutathione metabolism. Biol. Pharm. Bull., <b>45<\/b>, 1232-1237.","DOI":"10.1248\/bpb.b22-00045"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Uetrecht, J.P. (1992): The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions. Drug Metab. Rev., <b>24<\/b>, 299-366.","DOI":"10.3109\/03602539208996297"},{"key":"24","unstructured":"Uetrecht, J.P., Zahid, N. and Whitfield, D. (1994): Metabolism of vesnarinone by activated neutrophils: implications for vesnarinone-induced agranulocytosis. J. Pharmacol. Exp. Ther., <b>270<\/b>, 865-872."},{"key":"25","doi-asserted-by":"crossref","unstructured":"Uetrecht, J.P. (1996): Reactive metabolites and agranulocytosis. Eur. J. Haematol. Suppl., <b>60<\/b> (Suppl., 60), 83-88.","DOI":"10.1111\/j.1600-0609.1996.tb01651.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Uetrecht, J. and Naisbitt, D.J. (2013): Idiosyncratic adverse drug reactions: current concepts. Pharmacol. Rev., <b>65<\/b>, 779-808.","DOI":"10.1124\/pr.113.007450"},{"key":"27","doi-asserted-by":"publisher","unstructured":"Yamada, M., Mori, M. and Sugimura, T. (1981): Purification and characterization of small molecular weight myeloperoxidase from human promyelocytic leukemia HL-60 cells. Biochemistry, <b>20<\/b>, 766-771.","DOI":"10.1021\/bi00507a018"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/49\/3\/49_95\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T04:26:10Z","timestamp":1709353570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/49\/3\/49_95\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.49.95","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}